News
GPCR Safety Panels Launched

We are pleased to introduce our new GPCR Safety Panels, designed to help evaluate the off-target potency of ca […]

Read more
News
Core Technology for Our GPCR Functional Assay Patented in Japan

We are pleased to announce that the core technology for our GPCR functional assay has been patented in Japan. […]

Read more
News
Panel Assay Service Launched

株式会社タンソーバイオサイエンス(本社:東京都文京区、代表取締役:小笠原英明、以下タンソー)は、ヒトGタンパク質共役型受容体(GPCR) 297種に対するパネルアッセイサービスを開始しました。業界最大規模の網羅的パネルアッセイに加え、カスタマイズ自在でお求めやすい48受容体パネル「FlexPanel48」を提供します。

Read more
News
Interview with Tanso Biosciences CEO by NIKKEI Biotech

At the interview by NIKKEI Biotech, CEO Hideaki Ogasawara talks about Tanso Biosciences' proprietary GPCR func […]

Read more
Uncategorized
Distributor agreement with Cosmo Bio

Tanso Biosciences, Inc. has entered into a distributor agreement with Cosmo Bio Co., Ltd to provide contract a […]

Read more
Resources
GPCR ranking: Number of receptor-targeted drugs

All GPCRs are not made equal. As illustrated in "About GPCR," some GPCRs have dozens of drugs targeting them w […]

Read more